Cell Therapeutics, Inc. (CTIC) Management Discusses Q2 2013 Results (Webcast)

Jul.31.13 | About: CTI BioPharma (CTIC)

Cell Therapeutics (CTIC): Q2 EPS of -$0.17 in-line. Revenue of $306K beats by $1194M. (PR)

The following audio is from an earnings conference call that began on July 31, 2013, at 4:30 PM ET. The audio is live-streaming while the call is active, and can be replayed upon its completion.